Purchase Order 75N93018P01334
Award Date 9/14/18
Potential Completion Date 6/2/20
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- This is a $1,147,346.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company. The contract is for customized biological services to support the development and testing of therapeutic antibody and vaccine candidates by NIAID's Vaccine Research Center. This includes services such as plasmid preparation, protein production, and gene to...
- This is a $49,653.58 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for customized DNA and monoclonal antibody production services, with a completion date of September 5, 2020. Genscript, a for-profit organization, has established itself as a critical vendor for federal...
- This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...
- This is a $186,509 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company. The contract is for testing expression and purification services for virus glycoproteins in vitro. This requirement was sole-sourced to Genscript under the authority of FAR 13.106-1, as NIAID determined Genscript to be the only responsible source that...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company. The $118,272.00 contract is for the provision of customized antibody expressions and plasmid preparations to support biomedical research and public health initiatives. The award has a completion date of November 1, 2020 and does not include a set-aside designation. Genscript...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $70,395.88 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the delivery of antibody production and gene synthesis services, including mammalian expression, cloning, and plasmid preparation, to support NIAID's biomedical research and public health initiatives....
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...